.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Mallinckrodt
Baxter
Johnson and Johnson
US Department of Justice
McKinsey
Accenture
Citi
Medtronic
Covington

Generated: July 25, 2017

DrugPatentWatch Database Preview

ISOSORBIDE MONONITRATE Drug Profile

« Back to Dashboard

Which patents cover Isosorbide Mononitrate, and when can generic versions of Isosorbide Mononitrate launch?

Isosorbide Mononitrate is a drug marketed by Actavis Elizabeth, Hikma Pharms, Dexcel Ltd, Alkermes Gainesville, Ani Pharms Inc, Ivax Sub Teva Pharms, Kremers Urban Pharms, Hikma Pharms Llc, Skyepharma Ag, Torrent Pharms, Nesher Pharms, and Vintage Pharms. and is included in fourteen NDAs.

The generic ingredient in ISOSORBIDE MONONITRATE is isosorbide mononitrate. There are thirty-seven drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the isosorbide mononitrate profile page.

Summary for Tradename: ISOSORBIDE MONONITRATE

Patents:0
Applicants:12
NDAs:14
Suppliers / Packagers: see list31
Bulk Api Vendors: see list43
Clinical Trials: see list50
Patent Applications: see list5,007
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ISOSORBIDE MONONITRATE at DailyMed

Pharmacology for Tradename: ISOSORBIDE MONONITRATE

Ingredient-typeNitrates
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Elizabeth
ISOSORBIDE MONONITRATE
isosorbide mononitrate
TABLET, EXTENDED RELEASE;ORAL075306-001Dec 31, 1998DISCNNoNo► Subscribe► Subscribe► Subscribe
Skyepharma Ag
ISOSORBIDE MONONITRATE
isosorbide mononitrate
TABLET, EXTENDED RELEASE;ORAL075166-001Oct 7, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Torrent Pharms
ISOSORBIDE MONONITRATE
isosorbide mononitrate
TABLET, EXTENDED RELEASE;ORAL200495-002Jun 3, 2011ABRXNoNo► Subscribe► Subscribe► Subscribe
Actavis Elizabeth
ISOSORBIDE MONONITRATE
isosorbide mononitrate
TABLET;ORAL075037-002Oct 30, 1998ABRXNoNo► Subscribe► Subscribe► Subscribe
Hikma Pharms
ISOSORBIDE MONONITRATE
isosorbide mononitrate
TABLET, EXTENDED RELEASE;ORAL076813-001Jan 7, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Citi
Fuji
Argus Health
Baxter
Fish and Richardson
Dow
UBS
Covington
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot